IFNA1 and oral lichen planus: The other controversy that exists with anti-TNFα biological therapies (which might also be a treatment option in OLP cases) is that they may cause OLP formation as a result of reducing TNFα levels, with the parallel increase in interferon α (IFN) levels, which can create an environment that is favoured by T cell proliferation, leading to OLP eruptions [10].